Genertec Universal Medical Group Company ( (HK:2666) ) has shared an announcement.
Genertec Universal Medical Group Company Limited has successfully completed the issuance of the second tranche of its corporate bonds in the People’s Republic of China, totaling RMB 600 million. The bonds have a five-year term with a fixed interest rate of 2.10%, and various options are available for both the issuer and investors, potentially impacting the company’s financial operations and market positioning.
More about Genertec Universal Medical Group Company
Genertec Universal Medical Group Company Limited operates in the healthcare industry, focusing on medical services and healthcare-related leasing. It is primarily engaged in providing healthcare solutions and services in the People’s Republic of China.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $1.08B
For a thorough assessment of 2666 stock, go to TipRanks’ Stock Analysis page.